Bml Capital Management, LLC Lava Therapeutics Nv Transaction History
Bml Capital Management, LLC
- $124 Billion
- Q1 2025
A detailed history of Bml Capital Management, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Bml Capital Management, LLC holds 1,960,610 shares of LVTX stock, worth $2.39 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
1,960,610Holding current value
$2.39 Million% of portfolio
2.02%Shares
1 transactions
Others Institutions Holding LVTX
# of Institutions
24Shares Held
5.32MCall Options Held
100Put Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.53 Million0.16% of portfolio
-
Bruce & Co., Inc. Chicago, IL772KShares$941,6860.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3126KShares$154,1200.03% of portfolio
-
Pathway Financial Advisors LLC103KShares$125,0500.03% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$79,3000.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $31.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...